References
- KulkarniAEhrenkranzRABhandariVEffect of introduction of synchronized nasal intermittent positive-pressure ventilation in a neonatal intensive care unit on bronchopulmonary dysplasia and growth in preterm infantsAm J Perinatol200623423324016625501
- JegatheesanPKellerRLHawgoodSEarly variable-flow nasal continuous positive airway pressure in infants ≤ 1000 grams at birthJ Perinatol200626318919616453007
- World Health OrganisationThe global burden of disease: 2004 update2008 Available from: http://www.who.int/healthinfo/global_burden_disease/GBD_report_2004update_full.pdfAccessed on December 15, 2011
- OuyangLGrosseSDArmourBSWaitzmanNJHealth care expenditures of children and adults with spina bifida in a privately insured US populationBirth Defects Res A Clin Mol Teratol200779755255817335056
- FinanAClarkeTAMatthewsTGStrategies for reduction of neonatal mortalityIr J Med Sci1999168426526710624368
- WaldNJFolic acid and the prevention of neural-tube defectsN Engl J Med2004350210110314711907
- van der LindenIJMAfmanLAHeilSGBlomHJGenetic variation in genes of folate metabolism and neural-tube defect riskProc Nutri Soc20066502204215
- BuccimazzaSSMoltenoCDDunneTTViljoenDLPrevalence of neural tube defects in Cape Town, South AfricaTeratology19945031941997871483
- ChatkuptSSkurnickJHJaggiMMitrukaKKoenigsbergerMRJohnsonWGStudy of genetics, epidemiology, and vitamin usage in familial spina bifida in the United States in the 1990sNeurology199444165658290094
- MilunskyAAlpertENeffRKFrigolettoFDJrPrenatal diagnosis of neural tube defects: IV. Maternal serum alpha-fetoprotein screeningObstet Gynecol198055160666153240
- HallJSolehdinFFolic acid for the prevention of congenital anomaliesEur J Pediatr199815764454509667396
- BecerraJEKhouryMJCorderoJFEricksonJDDiabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control studyPediatrics1990851192404255
- LammerEJSeverLEOakleyGPJrValproic acidTeratology19873534654733114906
- EdwardsMJShiotaKSmithMSRWalshDAHyperthermia and birth defectsReprod Toxicol1995954114258563185
- GrahamJMJrEdwardsMJTeratogen update: gestational effects of maternal hyperthermia due to febrile illnesses and resultant patterns of defects in humansTeratology19985852092219839360
- ShawGMVelieEMSchafferDRisk of neural tube defect-affected pregnancies among obese womenJAMA199627514109310968601928
- WatkinsMLScanlonKSMulinareJKhouryMJIs maternal obesity a risk factor for anencephaly and spina bifida?Epidemiology1996755075128862982
- WerlerMMLouikCShapiroSMitchellAAPrepregnant weight in relation to risk of neural tube defectsJAMA199627514108910928601927
- BrenderJDFelknerMSuarezLCanfieldMAHenryJPMaternal pesticide exposure and neural tube defects in Mexican AmericansAnn Epidemiol2010201162220006272
- BlatterBMRoeleveldNZielhuisGAMullaartRAGabreëlsFJMSpina bifida and parental occupationEpidemiology1996721881938834560
- ShawGMNelsonVOlshanAFPaternal occupational group and risk of offspring with neural tube defectsPaediatr Perinat Epidemiol200216432833312445149
- LaurenceKMCarterCODavidPAMajor central nervous system malformations in South Wales. II. Pregnancy factors, seasonal variation, and social class effectsBr J Prev Soc Med19682242122224882275
- WassermanCRShawGMSelvinSGouldJBSymeSLSocioeconomic status, neighborhood social conditions, and neural tube defectsAm J Public Health19988811167416809807535
- VrijheidMDolkHStoneDAbramskyLAlbermanEScottJESSocioeconomic inequalities in risk of congenital anomalyArch Dis Child200082534935210799420
- ElwoodJMLittleJElwoodJHEpidemiology and Control of Neural Tube DefectsNew York, NYOxford University Press1992
- GrewalJCarmichaelSLSongJShawGMNeural tube defects: an analysis of neighbourhood- and individual- level socio-economic characteristicsPaediatr Perinatal Epidemiol2009232116124
- ChanARobertsonEFHaanEAKeaneRJRanieriECarneyAPrevalence of neural tube defects in South Australia, 1966–1991: effectiveness and impact of prenatal diagnosisBr Med J199330769067037068401091
- MorrisJKWaldNJPrevalence of neural tube defect pregnancies in England and Wales from 1964 to 2004J Med Screen2007142555917626701
- ChangoAEmery-FillonNde CourcyGPA polymorphism (80G-> A) in the reduced folate carrier gene and its associations with folate status and homocysteinemiaMol Genet Metab200070431031510993718
- van der PutNMJGabreëlsFStevensEA second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?Am J Human Genetics1998625104410519545395
- Van BeynumIMKapustaLDen HeijerMMaternal MTHFR 677C> T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementationEur Heart J200627898198716524890
- BottoLDOlneyRSEricksonJDVitamin supplements and the risk for congenital anomalies other than neural tube defectsAm J Med Genet C (Semin Med Genet)2004125122114755429
- BaleJStollBLucasAReducing Birth Defects: Meeting the Challenge in the Developing WorldWashington, DCThe National Academies Press2003
- ModellBKulievAMImpact of public health on human geneticsClin Genet19893652862982689000
- AlwanAModellBCommunity Control of Genetic and Congenital DisordersAlexandria, EgyptWHO Regional Office for the Eastern Mediterranean1997
- AhmanEZupanJNeonatal and Perinatal MortalityGeneva, SwitzerlandWorld Health Organization2006
- MilunskyACanickJAMaternal serum screening for neural tube and other defects and fetal chromosome abnormalitiesWest J Med199315933123177694429
- DuthieSJFolic acid deficiency and cancer: mechanisms of DNA instabilityBr Med Bull199955357859210746348
- PitkinRMFolate and neural tube defectsAm J Clin Nutr2007851285S288S17209211
- De BenoistBConclusions of a WHO Technical Consultation on folate and vitamin B12 deficienciesFood Nutr Bull200829Suppl 2S238S24418709899
- RefsumHSmithADAre we ready for mandatory fortification with vitamin B-12?Am J Clin Nutr200888225325418689357
- MakedosGPapanicolaouAHitoglouAHomocysteine, folic acid and B12 serum levels in pregnancy complicated with preeclampsiaArch Gynecol Obstet2007275212112416941105
- PatrickTEPowersRWDaftaryARNessRBRobertsJMHomocysteine and folic acid are inversely related in black women with preeclampsiaHypertension20044361279128215096466
- TamuraTPiccianoMFFolate and human reproductionAm J Clin Nutr2006835993101616685040
- CalongeNPetittiDBDeWittTGFolic acid for the prevention of neural tube defects: US Preventive Services Task Force recommendation statementAnn Intern Med2009150962663119414842
- WaldNSneddonJDensemJFrostCStoneRPrevention of neural tube defects: results of the Medical Research Council Vitamin StudyLancet199133887601311371677062
- CzeizelAEDudasIPrevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementationN Engl J Med199232726183218351307234
- ShibuyaKMurrayCJLLow birth weightMurrayCJLLopezADHealth Dimensions of Sex and ReproductionGlobal Burden of Disease and Injury SeriesCambridge: MAHarvard University Press1998
- De-RegilLMFernandez-GaxiolaACDowswellTPena-RosasJPEffects and safety of periconceptional folate supplementation for preventing birth defectsCochrane Database Sys Reviews201010CD007950
- BlencoweHCousensSModellBLawnJFolic acid to reduce neonatal mortality from neural tube disordersInt J Epidemiol201039Suppl 1i110i12020348114
- McNultyHPentievaKFolate bioavailabilityProc Nutr Soc200463452953615831124
- World Health OrganizationPrevention of Neural Tube Defects. Standards for Maternal and Neonatal CareGeneva, SwitzerlandWorld Health Organization2009
- Unicef, United Nations, World Health OrganizationIron Deficiency Anaemia: Assessment, Prevention, and Control: A Guide for Programme ManagersGeneva, SwitzerlandWorld Health Organization2001
- TaylorTNFarkouhRAGrahamJBColligsALindemannMLynenRCandrilliSDPotential reduction in neural tube defects associated with use of Metafolin-fortified oral contraceptives in the United StatesAm J Obstet Gynecol20112055460.e1821903192
- DiefenbackKTrummerDEbertFLissyMRohdeBBlodeHChanges in folate levels following cessation of Yasmin and levomefolate calcium 0.451 mg or folic acid 400 mcg coadministrationEur J Contracept Reprod Health Care201015Suppl 115715820465398
- FAD Beyaz Highlights of Prescribing Information2010 http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022532s000lbl.pdfAccessed on March 22, 2012
- MarrJSampson-LandersCDiefenbachKTrummerDBartSBlodeHFolate and homocysteine levels after 24 weeks administration of YAZ levomefolate calcium 0.451 mgEur J Contracept Reprod Health Care201015Suppl 1159
- BartSSrMarrJDiefenbachKTrummerDSampson-LandersCFolate status and homocysteine levels during a 24-week oral administration of a folate-containing oral contraceptive: a randomized, double-blind, active-controlled, parallel-group, US-based multicenter studyContraception2010851425022067790
- Bayer HealthCare PharmaceuticalsBeyaz prescribing information2010 Available from: http://berlex.bayerhealthcare.com/html/products/pi/fhc/Beyaz_PI.pdfAccessed February 10, 2012